1. Home
  2. CMRE vs VERV Comparison

CMRE vs VERV Comparison

Compare CMRE & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMRE
  • VERV
  • Stock Information
  • Founded
  • CMRE 1974
  • VERV 2018
  • Country
  • CMRE Monaco
  • VERV United States
  • Employees
  • CMRE N/A
  • VERV N/A
  • Industry
  • CMRE Marine Transportation
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • CMRE Consumer Discretionary
  • VERV Health Care
  • Exchange
  • CMRE Nasdaq
  • VERV Nasdaq
  • Market Cap
  • CMRE 1.0B
  • VERV 1.0B
  • IPO Year
  • CMRE 2010
  • VERV 2021
  • Fundamental
  • Price
  • CMRE $9.59
  • VERV $10.91
  • Analyst Decision
  • CMRE Hold
  • VERV Buy
  • Analyst Count
  • CMRE 2
  • VERV 11
  • Target Price
  • CMRE $13.50
  • VERV $14.57
  • AVG Volume (30 Days)
  • CMRE 479.1K
  • VERV 3.3M
  • Earning Date
  • CMRE 07-30-2025
  • VERV 08-07-2025
  • Dividend Yield
  • CMRE 4.83%
  • VERV N/A
  • EPS Growth
  • CMRE N/A
  • VERV N/A
  • EPS
  • CMRE 2.44
  • VERV N/A
  • Revenue
  • CMRE $2,054,690,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • CMRE N/A
  • VERV $47.32
  • Revenue Next Year
  • CMRE N/A
  • VERV N/A
  • P/E Ratio
  • CMRE $3.92
  • VERV N/A
  • Revenue Growth
  • CMRE 18.22
  • VERV 271.44
  • 52 Week Low
  • CMRE $6.63
  • VERV $2.87
  • 52 Week High
  • CMRE $15.96
  • VERV $11.41
  • Technical
  • Relative Strength Index (RSI)
  • CMRE 59.66
  • VERV 73.40
  • Support Level
  • CMRE $9.14
  • VERV $11.16
  • Resistance Level
  • CMRE $9.54
  • VERV $11.08
  • Average True Range (ATR)
  • CMRE 0.27
  • VERV 0.11
  • MACD
  • CMRE 0.01
  • VERV -0.25
  • Stochastic Oscillator
  • CMRE 90.14
  • VERV 2.27

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: